We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVA icon
451
Innoviva
INVA
$1.61B
$32.2K ﹤0.01%
1,602
– –
IMCR icon
452
Immunocore
IMCR
$1.7B
$31.8K ﹤0.01%
1,014
– –
EWTX icon
453
Edgewise Therapeutics
EWTX
$4.35B
$31.8K ﹤0.01%
2,424
– –
TXG icon
454
10x Genomics
TXG
$6.02B
$31.7K ﹤0.01%
2,739
– –
GPCR icon
455
Structure Therapeutics
GPCR
$3.4B
$31.6K ﹤0.01%
1,525
– –
CVAC
456
DELISTED
CureVac
CVAC
$31.2K ﹤0.01%
5,744
– –
AUPH icon
457
Aurinia Pharmaceuticals
AUPH
$1.93B
$31.1K ﹤0.01%
3,666
– –
JANX icon
458
Janux Therapeutics
JANX
$904M
$31K ﹤0.01%
1,343
– –
CNTA
459
DELISTED
Centessa Pharmaceuticals
CNTA
$30K ﹤0.01%
2,283
– –
AUR icon
460
Aurora
AUR
$12.2B
$29.8K ﹤0.01%
+5,692
New +$35.7K
ETNB
461
DELISTED
89bio
ETNB
$29.6K ﹤0.01%
3,011
– –
KNSA icon
462
Kiniksa Pharmaceuticals
KNSA
$6.08B
$29.4K ﹤0.01%
1,064
– –
SHO icon
463
Sunstone Hotel Investors
SHO
$2.21B
$29.3K ﹤0.01%
3,371
-253
-7% -$2.18K
LTC
464
LTC Properties
LTC
$2.16B
$28.3K ﹤0.01%
818
-39
-5% -$1.37K
PCRX icon
465
Pacira BioSciences
PCRX
$1.05B
$28.3K ﹤0.01%
1,182
– –
AMPH icon
466
Amphastar Pharmaceuticals
AMPH
$898M
$28.2K ﹤0.01%
1,230
– –
GRFS
467
Grifois
GRFS
$5.59B
$28.2K ﹤0.01%
3,123
– –
DRH icon
468
Diamondrock Hospitality Co
DRH
$2.7B
$28.2K ﹤0.01%
3,683
-249
-6% -$1.86K
HROW icon
469
Harrow
HROW
$1.45B
$27.8K ﹤0.01%
911
– –
IIPR icon
470
Innovative Industrial Properties
IIPR
$1.77B
$27.6K ﹤0.01%
500
-37
-7% -$2.03K
MNKD icon
471
MannKind Corp
MNKD
$1.2B
$26.4K ﹤0.01%
7,061
– –
ABCL icon
472
AbCellera Biologics
ABCL
$1.67B
$25.9K ﹤0.01%
7,563
– –
GNL icon
473
Global Net Lease
GNL
$1.87B
$25.9K ﹤0.01%
3,429
-284
-8% -$2.15K
NVAX icon
474
Novavax
NVAX
$1.22B
$25.8K ﹤0.01%
4,101
– –
GTY
475
Getty Realty Corp
GTY
$2.19B
$25.5K ﹤0.01%
922
-68
-7% -$1.95K
17 18
19
20 21

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.